Daten zum Nutzen-Risiko-Verhältnis für COVID-19-Impfstoffen

This procedure is a written question submitted to the German Bundestag seeking specific data and analysis regarding the benefit-risk ratio of COVID-19 vaccines. It aims to provide transparency on the effectiveness and safety profiles of the vaccinations used during the pandemic. The information requested affects public health policy and provides transparency for citizens and healthcare providers regarding the safety monitoring of vaccines.